跳到主页内容
Access keys NCBI Homepage myncbi主页 主要内容 Main Navigation

Search Page

My NCBI Filters
一年一度的结果

搜索结果时间表的表表示，每年搜索结果数量。

Year 结果数
1954年 1
1955年 1
1996 1
1998 1
1999 1
2000 1
2001 1
2003 7
2004 4
2005 11
2006 14
2007 16
2008 15
2009 16
2010 20
2011 22
2012 36
2013 24
2014 24
2015 36
2016 22
2017 28
2018 26
2019 20
2020 28
2021 15
Text availability
Article attribute
Article type
Publication date

Search Results

317results
一年一度的结果
过滤器applied:.Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
Shitara K, Bang YJ, Iwasa S, Sugimoto N,Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Yamaguchi K; DESTINY-Gastric01 Investigators. Shitara K等。在作者中：ryu mh. N Engl J Med。2020年6月18日； 382（25）：2419-2430。doi：10.1056/nejmoa2004413。EPUB 2020年5月29日。 N Engl J Med。2020。 PMID：32469182 Clinical Trial.
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
Abou-Alfa GK，Meyer T，Cheng AL，El-Khoueiry AB，Rimassa L，Ryoo by，Cicin I，Cicin I，Merle P，Chen Y，Park JW，Blanc JF，Bolondi JF，Bolondi L，KlümpenHJ，Chan SL，Chan SL，Zagonel V，Pressianii V，Pressianii v，Pressianii v，Pressianii v，Pressianii v，Pressianiit，Ryu MH, Venook AP, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK. Abou-Alfa GK等。在作者中：ryu mh. N Engl J Med。2018 Jul 5;379(1):54-63. doi: 10.1056/NEJMoa1717002. N Engl J Med。2018. PMID：29972759 Free PMC article. Clinical Trial.
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kang YK，Boku N，Satoh T，Ryu MH，Chao Y，Kato K，Chung HC，Chen JS，Muro K，Kang WK，Yeh KH，Yoshikawa T，OH SC，Bai Ly，Tamura T，Lee KW，Lee KW，Hamamoto Y，Kim JG，Kim JG，Chin K，Chin K，Chin K，Oh Oh Dy，Minashi，Minashi，Minashi，Minashi，MinashiK，Cho Jy，Tsuda M，Chen Lt。 Kang YK, et al. Among authors:ryu mh. Lancet. 2017 Dec 2;390(10111):2461-2471. doi: 10.1016/S0140-6736(17)31827-5. Epub 2017 Oct 6. Lancet. 2017. PMID：28993052 Clinical Trial.
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Shitara K, Özgüroğlu M, Bang YJ, Di Bartolomeo M, Mandalà M,Ryu MH, Fornaro L, Olesiński T, Caglevic C, Chung HC, Muro K, Goekkurt E, Mansoor W, McDermott RS, Shacham-Shmueli E, Chen X, Mayo C, Kang SP, Ohtsu A, Fuchs CS; KEYNOTE-061 investigators. Shitara K等。在作者中：ryu mh. Lancet. 2018 Jul 14;392(10142):123-133. doi: 10.1016/S0140-6736(18)31257-1. Epub 2018 Jun 4. Lancet. 2018. PMID：29880231 Clinical Trial.
Nivolumab与先前未经治疗，不可切除，晚期或复发性胃/胃食管治疗癌症患者的S-1/Capecitabine Plus Oxaliptin结合使用的安全性和功效：一项随机，II期试验的随机结果（Actraction-4）。
Boku N,Ryu MH，Kato K，Chung HC，Minashi K，Lee KW，Cho H，Kang WK，Komatsu Y，Tsuda M，Yamaguchi K，Hara H，Fumita S，Azuma M，Chen lt，Kang YK。 Boku N等。在作者中：ryu mh. 安·恩科尔（Ann Oncol）。2019 Feb 1;30(2):250-258. doi: 10.1093/annonc/mdy540. 安·恩科尔（Ann Oncol）。2019. PMID：30566590 Free PMC article. Clinical Trial.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Chen LT, Satoh T,Ryu MH，Chao Y，Kato K，Chung HC，Chen JS，Muro K，Kang WK，Yeh KH，Yoshikawa T，OH SC，Bai Ly，Tamura T，Lee KW，Lee KW，Hamamoto Y，Kim JG，Kim JG，Chin K，Chin K，Chin K，Oh Oh Dy，Minashi，Minashi，Minashi，Minashi，MinashiK, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N. Chen LT, et al. Among authors:ryu mh. 胃癌。2020 May;23(3):510-519. doi: 10.1007/s10120-019-01034-7. Epub 2019 Dec 20. 胃癌。2020。 PMID：31863227 Free PMC article. Clinical Trial.
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.
Bang YJ，Ruiz Ey，Van Cutsem E，Lee KW，Wyrwicz L，Schenker M，Alsina M，Ryu MH, Chung HC, Evesque L, Al-Batran SE, Park SH, Lichinitser M, Boku N, Moehler MH, Hong J, Xiong H, Hallwachs R, Conti I, Taieb J. Bang YJ, et al. Among authors:ryu mh. 安·恩科尔（Ann Oncol）。2018年10月1日； 29（10）：2052-2060。doi：10.1093/annonc/mdy264。 安·恩科尔（Ann Oncol）。2018. PMID：30052729 Free PMC article. Clinical Trial.
在吸引力-2试验中对先前曲妥珠单抗使用的患者的探索性亚组分析：一项随机III期临床试验，研究了Nivolumab在晚期胃/胃食管治疗癌症患者中的疗效和安全性。
Satoh T, Kang YK, Chao Y,Ryu MH, Kato K, Cheol Chung H, Chen JS, Muro K, Ki Kang W, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Tanimoto M, Chen LT, Boku N. Satoh T等。在作者中：ryu mh. 胃癌。2020 Jan;23(1):143-153. doi: 10.1007/s10120-019-00970-8. Epub 2019 May 13. 胃癌。2020。 PMID：31087200 Free PMC article. Clinical Trial.
Control of nitrogen fixation in bacteria that associate with cereals.
Ryu MH, Zhang J, Toth T, Khokhani D, Geddes BA, Mus F, Garcia-Costas A, Peters JW, Poole PS, Ané JM, Voigt CA. Ryu MH, et al. Nat Microbiol. 2020 Feb;5(2):314-330. doi: 10.1038/s41564-019-0631-2. Epub 2019 Dec 16. Nat Microbiol. 2020. PMID：31844298
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Kang YK, Chin K, Chung HC, Kadowaki S, Oh SC, Nakayama N, Lee KW, Hara H, Chung IJ, Tsuda M, Park SH, Hosaka H, Hironaka S, Miyata Y,Ryu MH，Baba H，Hyodo I，Bang YJ，Boku N. Kang YK, et al. Among authors:ryu mh. Lancet Oncol. 2020 Aug;21(8):1045-1056. doi: 10.1016/S1470-2045(20)30315-6. Epub 2020 Jul 16. Lancet Oncol. 2020. PMID：32682457 Clinical Trial.
317results
You have reached the last page of results. A maximum of 10,000 results are available.
Jumpto page